Anzeige
❌
Mehr »
Samstag, 31.10.2026 - Börsentäglich über 12.000 News
Tiefsee-Explorer bricht Chinas Kobalt-Monopol
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Renaissance Capital

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
23.10.Emerging markets fintech OPay sets terms for $320 million US IPO
23.10.Switzerland-based respiratory biotech Windward Bio Group files for a $100 million US IPO
23.10.Lycia Therapeutics prices upsized IPO at $18, the high end of the range
22.10.Inflammatory diseases biotech Rezera files for an estimated $100 million IPO
22.10.Inflammatory diseases biotech Rezera files for a $100 million IPO
21.10.China-based AI vision solutions provider Sensing4D AI files for a $35 million US IPO
21.10.Africa-linked IPOs pick up steam in 2026
20.10.Allergy and autoimmune biotech Lycia Therapeutics sets terms for $250 million IPO
20.10.Space systems developer Gravitics Holdings slashes share offering by 60% ahead of $50 million IPO
20.10.UK-based nursery operator iStep Learning files for a $18 million US IPO
19.10.Chinese equipment maker Kepuni Holdings withdraws $15 million US IPO
19.10.SPACCircle Acquisition lowers deal size by 33% ahead of $100 million IPO
17.10.US IPO Week Ahead: IPO calendar stays quiet ahead of potential Anthropic filing
17.10.US IPO Weekly Recap: Biotechs City Therapeutics and Iambic headline the week's pricings
16.10.Pan-Asian travel booking platform Klook Technology withdraws estimated $400 million US IPO
16.10.SPAC TCGX Acquisition II prices $100 million IPO, targeting healthcare in Asia
16.10.City Therapeutics prices upsized IPO at $18, the midpoint of the range
15.10.Small molecule biotech Iambic Therapeutics prices IPO at $16, the midpoint of the range
15.10.Metal powder producer Amaero prices downsized US IPO at $4.25 per share
15.10.Tungsten Miners Weigh IPOs Following Price Surge
14.10.Cardiac medical device developer BioVentrix withdraws $17 million IPO
14.10.Biotech-focused SPAC Frazier Life Sciences Acquisition II prices $75 million IPO
14.10.IPO Weekly Weigh-in: Why investors said no to this $3.5B AI IPO
14.10.SPAC Hall Chadwick Acquisition II lowers deal size by 25% ahead of $200 million IPO
13.10.SPAC EuroSPAC Acquisition files for a $125 million US IPO, led by the CEO of Euroseas